The impact of maternal obesity on childhood neurodevelopment

Lilin Tong1, Brian T Kalish2

  • 1Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.

Insights

Maternal obesity may increase children's risk for neurodevelopmental and neuropsychiatric disorders. Understanding these links is vital for intervention strategies amid the global obesity epidemic.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Public Health

Background:

  • Maternal obesity is a growing global health concern.
  • Evidence suggests a link between maternal obesity and offspring neurodevelopmental and neuropsychiatric disorders.
  • A comprehensive understanding is needed to address this public health issue.

Purpose of the Study:

  • To review existing human and animal studies on maternal obesity and offspring brain health.
  • To identify key biological mechanisms mediating these effects.
  • To propose future research and intervention strategies.

Main Methods:

  • Systematic review of human and animal research.
  • Analysis of studies investigating maternal obesity and child neurodevelopment.
  • Synthesis of evidence on underlying biological pathways.

Main Results:

  • Maternal obesity is associated with increased risk of neurodevelopmental and neuropsychiatric issues in offspring.
  • Key mechanisms include inflammation, microbiome alterations, epigenetic changes, and neurotransmitter pathway disruptions.
  • Evidence spans both clinical observations and experimental models.

Conclusions:

  • Maternal obesity poses a significant risk to offspring brain development and mental health.
  • Intervention and further research are crucial to mitigate these risks.
  • Targeting identified mechanisms may offer therapeutic avenues.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
950
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
575
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.6K
Environmental Influences on Intelligence01:29

Environmental Influences on Intelligence

Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children...
678
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
83
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K